Dr. Schnabl received his medical degree from the University of Freiburg in Germany. During his three-year postdoctoral research training at the Department of Medicine, Biochemistry & Biophysics at the University of North Carolina at Chapel Hill, he started to study hepatic stellate cell biology and pathophysiology of chronic liver diseases. He completed a residency in Medicine at the University Hospital in Regensburg/Germany and a Gastroenterology fellowship at Columbia University, College of Physicians and Surgeons, in New York City. The history of Columbia University and its renowned educational and research programs in both the basic sciences and in clinical health care provided a rich environment, in which he experienced excellent clinical training as a gastroenterologist as well as high-quality productive research.
He was recruited to the Division of Gastroenterology at UC San Diego in 2008 and he is currently an associate professor in residence. UCSD offers the best setting and infrastructure for pursuing research very efficiently and successfully. He is staff physician and attending at the VA San Diego Medical Center in La Jolla and the UCSD Medical Center.
His many honors include a Postdoctoral Research Fellowship Award from the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG), a Schering-Plough Unrestricted Educational Award from the European Foundation for the Study of Liver Diseases (EASL), an American Gastroenterological Association (AGA)/Astra Zeneca Fellowship - Faculty Transition Award (FFTA) and a K08 Career Development Award from the NIH/NIDDK. He was elected as full member to the prestigious American Society for Clinical Investigation (ASCI) in 2016. ASCI is North America's oldest and most respected medical honor society. To become ASCI member, outstanding young physician scientists must be nominated. ASCI selects less than 80 members each year from all areas of medicine for their significant research accomplishments. He was also selected as Fellow of the American Gastroenterological Association (AGAF) in 2016. He was chosen to present the Hans Popper Basic Science State-of-the-Art Lecture at the annual meeting of the American Association for the Study of Liver Diseases (AASLD) in 2017.
Dr. Schnabl has published extensively in such highly-regarded journals as Nature, Gastroenterology, Hepatology, Journal of Hepatology and Proceedings of the National Academy of Sciences and he has authored multiple reviews and book chapters. Dr. Schnabl is a member of 3 distinguished medical societies. He was recently elected as member to the American Society for Clinical Investigation (ASCI). He serves as Associate Editor for Digestive Diseases and Sciences, which is the oldest continuously published GI journal in North America. He is on the editorial board for several journals in the field of hepatology and reviewer for all of the top-tier medical journals.
Dr. Schnabl’s main research interests are:
- Genetic and molecular mechanisms of chronic liver disease progression
- Intestinal microbiome, metagenome and transcriptome associated with liver disease
- Contribution of microbial products and metabolites to liver disease